{
  "id": "56f12ca92ac5ed145900000e",
  "type": "yesno",
  "question": "Have gnotobiotic animal models been used for the study of bowel disease?",
  "ideal_answer": "Yes, gnotobiotic animals (e.g. mice) have been used for the study of bowel disease (e.g. inflammatory bowel disease).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/17145736",
    "http://www.ncbi.nlm.nih.gov/pubmed/11984521",
    "http://www.ncbi.nlm.nih.gov/pubmed/20004202",
    "http://www.ncbi.nlm.nih.gov/pubmed/24500617",
    "http://www.ncbi.nlm.nih.gov/pubmed/18841702",
    "http://www.ncbi.nlm.nih.gov/pubmed/24959425",
    "http://www.ncbi.nlm.nih.gov/pubmed/16127016",
    "http://www.ncbi.nlm.nih.gov/pubmed/16954804",
    "http://www.ncbi.nlm.nih.gov/pubmed/21426337",
    "http://www.ncbi.nlm.nih.gov/pubmed/21278760",
    "http://www.ncbi.nlm.nih.gov/pubmed/12906096",
    "http://www.ncbi.nlm.nih.gov/pubmed/2765093"
  ],
  "snippets": [
    {
      "text": "Host gene expression in the colon of gnotobiotic interleukin-2-deficient mice colonized with commensal colitogenic or noncolitogenic bacterial strains: common patterns and bacteria strain specific signatures.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16954804",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " Specific pathogen-free (SPF), but not germfree (GF), interleukin (IL)-2-deficient (IL-2-/-) mice develop inflammatory bowel disease (IBD) at 10 to 15 weeks of age. Gnotobiotic IL-2-/- mice monocolonized with E. coli mpk develop IBD at 25 to 33 weeks of age but not B. vulgatus mpk, E. coli Nissle 1917, or mice cocolonized with both E. coli mpk and B. vulgatus",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16954804",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21426337",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "To model inflammatory bowel disease, we assessed infection with Helicobacter hepaticus 3B1 (ATCC 51449) and a potential probiotic Lactobacillus reuteri (ATCC PTA-6475) in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice. No typhlocolitis developed in germ-free controls (n=21) or in L. reuteri (n=8) or H. hepaticus (n=18) mono-associated mice for 20 weeks post-infection. As positive controls, three specific pathogen-free IL-10(-/-) mice dosed with H. hepaticus developed severe typhlocolitis within 11 weeks. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21426337",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These data support that the development of typhlocolitis in H. hepaticus-infected IL-10(-/-) mice required co-colonization with other microbiota and in this study, required only L. reuteri. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21426337",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "When transferred to gnotobiotic mice, gut microbiomes from mice with active disease versus treatment-induced remission elicited varying degrees of colitis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24500617",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21278760",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The immunomodulatory effects of microbiota and probiotics for inflammatory bowel diseases and the role of bacteria in their etiologies are being studied in gnotobiotic systems.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18841702",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To model inflammatory bowel disease, we assessed infection with Helicobacter hepaticus 3B1 (ATCC 51449) and a potential probiotic Lactobacillus reuteri (ATCC PTA-6475) in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21426337",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Gnotobiotic piglets may be used as a suitable animal model to study colitis induced by C. jejuni",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2765093",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21278760",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We investigated the changes in renal expression of Kl as a consequence of colitis. METHODS: We studied 3 mouse models of IBD: colitis induced by trinitrobenzene sulfonic acid, colitis induced by microflora (in gnotobiotic interleukin-10(-/-)), and colitis induced by adoptive transfer of CD4(+)CD45RB(high) T cells. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20004202",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "METHODS: We studied 3 mouse models of IBD: colitis induced by trinitrobenzene sulfonic acid, colitis induced by microflora (in gnotobiotic interleukin-10(-/-)), and colitis induced by adoptive transfer of CD4(+)CD45RB(high) T cells. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20004202",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.disease-ontology.org/api/metadata/DOID:13419",
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003424",
    "http://www.disease-ontology.org/api/metadata/DOID:5143",
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D043183",
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015212",
    "http://www.disease-ontology.org/api/metadata/DOID:0050589",
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D055496",
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D058535",
    "http://www.disease-ontology.org/api/metadata/DOID:6880",
    "http://www.disease-ontology.org/api/metadata/DOID:8778"
  ],
  "exact_answer": "Yes"
}